Contrast-induced Acute Kidney Injury: A Review of Practical Points

Overview

Journal World J Nephrol

Publisher Baishideng Publishing Group

Specialty Nephrology

Date 2017 May 26

PMID 28540198

Citations 55

Authors

Sercin Ozkok

Abdullah Ozkok

Affiliations

Soon will be listed here.

Abstract

Contrast-induced acute kidney injury (CI-AKI) is one of the most common causes of AKI in clinical practice. CI-AKI has been found to be strongly associated with morbidity and mortality of the patients. Furthermore, CI-AKI may not be always reversible and it may be associated with the development of chronic kidney disease. Pathophysiology of CI-AKI is not exactly understood and there is no consensus on the preventive strategies. CI-AKI is an active research area thus clinicians should be updated periodically about this topic. In this review, we aimed to discuss the indications of contrast-enhanced imaging, types of contrast media and their impact on nephrotoxicity, major pathophysiological mechanisms, risk factors and preventive strategies of CI-AKI and alternative non-contrast-enhanced imaging methods.

Citing Articles

AI-powered contrast-free cardiovascular magnetic resonance imaging for myocardial infarction.

Cicek V, Bagci U Front Cardiovasc Med. 2024; 11:1457498.

PMID: 39639975 PMC: 11617551. DOI: 10.3389/fcvm.2024.1457498.

Proenkephalin A 119-159 in Perioperative and Intensive Care-A Promising Biomarker or Merely Another Option?.

Walczak-Wieteska P, Zuzda K, Malyszko J, Andruszkiewicz P Diagnostics (Basel). 2024; 14(21).

PMID: 39518330 PMC: 11545452. DOI: 10.3390/diagnostics14212364.

Risk Score for Predicting AKI from Contrast-Enhanced CT (Pre-CT AKI score): Training and Validation from Retrospective Cohort.

Pattharanitima P, Bumrungsong N, Phoompho B, Tanin R, Anumas S Kidney360. 2024; .

PMID: 39418104 PMC: 11793181. DOI: 10.34067/KID.0000000623.

Contrast-induced acute kidney injury: a review of definition, pathogenesis, risk factors, prevention and treatment.

Li Y, Wang J BMC Nephrol. 2024; 25(1):140.

PMID: 38649939 PMC: 11034108. DOI: 10.1186/s12882-024-03570-6.

Prevention of post-contrast kidney injury in patients with cancer.

Grassedonio E, Incorvaia L, Guarneri M, Guagnini F, Midiri M Drugs Context. 2024; 13.

PMID: 38510312 PMC: 10954291. DOI: 10.7573/dic.2023-11-2.

References

Polena S, Yang S, Alam R, Gricius J, Gupta J, Badalova N . Nephropathy in critically Ill patients without preexisting renal disease. Proc West Pharmacol Soc. 2006; 48:134-5. View

Haller C, Hizoh I . The cytotoxicity of iodinated radiocontrast agents on renal cells in vitro. Invest Radiol. 2004; 39(3):149-54. DOI: 10.1097/01.rli.0000113776.87762.49. View

Quintavalle C, Fiore D, De Micco F, Visconti G, Focaccio A, Golia B . Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury. Circulation. 2012; 126(25):3008-16. DOI: 10.1161/CIRCULATIONAHA.112.103317. View

Owen R, Hiremath S, Myers A, Fraser-Hill M, Barrett B . Canadian Association of Radiologists consensus guidelines for the prevention of contrast-induced nephropathy: update 2012. Can Assoc Radiol J. 2014; 65(2):96-105. DOI: 10.1016/j.carj.2012.11.002. View

Recio-Mayoral A, Chaparro M, Prado B, Cozar R, Mendez I, Banerjee D . The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO Study. J Am Coll Cardiol. 2007; 49(12):1283-8. DOI: 10.1016/j.jacc.2006.11.034. View

Cigarroa R, Lange R, Williams R, Hillis L . Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med. 1989; 86(6 Pt 1):649-52. DOI: 10.1016/0002-9343(89)90437-3. View

Yucel A, Kart-Koseoglu H, Demirhan B, Ozdemir F . Cholesterol crystal embolization mimicking vasculitis: success with corticosteroid and cyclophosphamide therapy in two cases. Rheumatol Int. 2005; 26(5):454-60. DOI: 10.1007/s00296-005-0012-4. View

Zhang Y, Wang J, Yang X, Wang X, Zhang J, Fang J . The serial effect of iodinated contrast media on renal hemodynamics and oxygenation as evaluated by ASL and BOLD MRI. Contrast Media Mol Imaging. 2012; 7(4):418-25. DOI: 10.1002/cmmi.1468. View

Eng J, Wilson R, Subramaniam R, Zhang A, Suarez-Cuervo C, Turban S . Comparative Effect of Contrast Media Type on the Incidence of Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis. Ann Intern Med. 2016; 164(6):417-24. DOI: 10.7326/M15-1402. View

10.

McCullough P, Wolyn R, Rocher L, Levin R, ONeill W . Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med. 1997; 103(5):368-75. DOI: 10.1016/s0002-9343(97)00150-2. View

11.

Wessely R, Koppara T, Bradaric C, Vorpahl M, Braun S, Schulz S . Choice of contrast medium in patients with impaired renal function undergoing percutaneous coronary intervention. Circ Cardiovasc Interv. 2009; 2(5):430-7. DOI: 10.1161/CIRCINTERVENTIONS.109.874933. View

12.

Brar S, Shen A, Jorgensen M, Kotlewski A, Aharonian V, Desai N . Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial. JAMA. 2008; 300(9):1038-46. DOI: 10.1001/jama.300.9.1038. View

13.

Rudnick M, Feldman H . Contrast-induced nephropathy: what are the true clinical consequences?. Clin J Am Soc Nephrol. 2008; 3(1):263-72. DOI: 10.2215/CJN.03690907. View

14.

Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W . Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med. 2000; 343(3):180-4. DOI: 10.1056/NEJM200007203430304. View

15.

Hamani A, Petitclerc T, Jacobs C, Deray G . Is dialysis indicated immediately after administration of iodinated contrast agents in patients on haemodialysis?. Nephrol Dial Transplant. 1998; 13(4):1051-2. View

16.

Patti G, Ricottini E, Nusca A, Colonna G, Pasceri V, DAmbrosio A . Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage.... Am J Cardiol. 2011; 108(1):1-7. DOI: 10.1016/j.amjcard.2011.03.001. View

17.

Ribichini F, Graziani M, Gambaro G, Pasoli P, Pighi M, Pesarini G . Early creatinine shifts predict contrast-induced nephropathy and persistent renal damage after angiography. Am J Med. 2010; 123(8):755-63. DOI: 10.1016/j.amjmed.2010.02.026. View

18.

Vogt B, Ferrari P, Schonholzer C, Marti H, Mohaupt M, Wiederkehr M . Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. Am J Med. 2001; 111(9):692-8. DOI: 10.1016/s0002-9343(01)00983-4. View

19.

Maioli M, Toso A, Leoncini M, Gallopin M, Musilli N, Bellandi F . Persistent renal damage after contrast-induced acute kidney injury: incidence, evolution, risk factors, and prognosis. Circulation. 2012; 125(25):3099-107. DOI: 10.1161/CIRCULATIONAHA.111.085290. View

20.

Cronin R . Contrast-induced nephropathy: pathogenesis and prevention. Pediatr Nephrol. 2009; 25(2):191-204. DOI: 10.1007/s00467-009-1204-z. View